Antoine BÉRET

Antoine BÉRET

Independent Director

Antoine Béret was Chief Executive Officer (CEO) of Genoscience Pharma SAS and Chairman of Axenis. He graduated from École Nationale des Ponts et Chaussées and Ecole Polytechnique. Antoine Béret co-founded several companies specializing in biomedicine, including Trophos where he served as CEO until 2008 and Immunotech that he directed until 1996 when Immunotech was acquired by Coulter Inc. He started his career as a civil engineer in both public and private sectors, then has been project manager in charge of funding industrial companies at Crédit National and directed and invested as a ‘business angel’ TxCell in 2001-2002.

Antoine Béret has been a Director of the Company since 2016.

Committees: Member of the Audit and Compensation Committees and Member of the Clinical Development Committee